This novel catheter-based technology allows precise remote manipulations within the intra-luminal space with precision and reproducibility that surpasses human capabilities.
For high-risk patients, a technique has been developed that involves inserting a new expandable wire mesh valve with internal valve leaflets.
This particular innovation uses RNA antisense technology to treat patients who are unable to reach their targeted cholesterol levels with statins alone or who are statin intolerant.
New genetic testing can be used to develop personalized risk assessments and disease management plans for variety of genetically caused diseases.
Newer anticoagulant treatments are being introduced with the goal of curbing complications such as bleeding and thrombosis.
Nasal drops containing live attenuated flu can be used as a vaccine in lieu of needles, and provide effective protection from influenza for this high-risk population.
This technology is used to diagnose medical problems, both anatomic and physiologic in nature, as well as to assist minimally invasive procedures-such as stent placement or tumor ablation.
Novel communication interfaces are being developed for severely motor-impaired individuals to provide the ability to control devices and to potentially restore limb movements.
Natural biomaterials have been developed to replace joint cartilage tissue damaged from injury or arthritis.
The CT device features two X-ray sources and two radiation detectors, which allow for imaging of patients more quickly and with less radiation.